投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
600.0元/篇
（网友贡献，非官方数据）
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
4.7 %
年文章数
919
NCBI查询
期刊简介
稿件收录要求
稿件收录要求
Cancer Research and Treatment is a peer-reviewed open access publication of the Korean Cancer Association. It is published quarterly, one volume per year. Abbreviated title is Cancer Res Treat. It accepts manuscripts relevant to experimental and clinical cancer research. Subjects include carcinogenesis, tumor biology, molecular oncology, cancer genetics, tumor immunology, epidemiology, predictive markers and cancer prevention, pathology, cancer diagnosis, screening and therapies including chemotherapy, surgery, radiation therapy, immunotherapy, gene therapy, multimodality treatment and palliative care.
Cancer Research and Treatment (CRT) is indexed/tracked/covered by SCI, Medline, PubMed, PubMed Central, KoreaMed, CrossRef, Chemical Abstracts Service (CAS), SCOPUS, KoMCI, and Google Scholar.
Cancer Research and Treatment (CRT) is indexed/tracked/covered by SCI, Medline, PubMed, PubMed Central, KoreaMed, CrossRef, Chemical Abstracts Service (CAS), SCOPUS, KoMCI, and Google Scholar.
